Activation of AMPK, a master sensor to regulate metabolism, might ameliorate NAFLD via increasing hepatic insulin sensitivity, consequently suppressing hepatic de novo lipogenesis and increasing fatty acid oxidation, as well as promoting mitochondrial function in adipose tissue [44]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.